Cannabis Sativa inc (OTC:CBDS) is a web retail company that focuses on the sale of CBD products – water, snacks, that sort of thing. The company has recently acquired iBudtender, a comprehensive medical cannabis resource. Patients can find cannabis medication based on their needs and preferences and medicate safely knowing exactly what is in their medicine and how to use it properly and safely. The one-of-a-kind system connects patients, dispensaries, businesses and providers together not just socially, but commercially and personally as well. The same product a provider adds to the system can be found and shared by patients, doctors, advocates and investors as well as added to dispensary menus creating a cycle of knowledge and awareness.
Cannabis Sativa. Inc continues to expand its product line with the announcement on April 13, 2017 that it has entered into a license agreement with White Rabbit for the manufacturing, marketing, and sale of White Rabbit’s products in the State of California. The White Rabbit product line includes fast acting low dose cannabis oral sprays and popular low dose cannabis mints. All exclusive and proprietary product formulations, product mixes, manufacturing methods and branding will be included in the acquisition. Cannabis Sativa’s President David Tobias stated:
“The White Rabbit line of products is very attractive to us given its low dose and metering, which are important qualities for medicinal use. The White Rabbit products are currently being sold throughout California. Upon closing, the Company will look to license the White Rabbit products for use in states where medical.”
Cannabis Sativa. Inc anticipates adding products to its California licensing agreement in the coming months. Moreover, the Company is seeking to engage additional licensees in states where medical cannabis is legal as soon as possible.
On April 21st through April 23rd at HempCon: 420 Freedom Festival, Americas largest cannabis industry, health, life style, culture & music expo held in San Francisco, Cannabis Sativa, Inc launched its new hi honey product. The day before HempCon, on April 20, 2017 (an appropriate data for the occasion), the Company announced that it has developed a “hi” branded infused honey product (hi honey) which is made from rich African honey and infused with CBD or THC. President of Cannabis Sativa, Inc David Tobias said that:
“the hi honey flavor is rich, dark and unique. Superfood honey contains powerful compounds including probiotics and polyphenols, which could help fight inflammation and protect cells from damage.”
Pre-production packaging of the hi honey product was available for sale at HempCon for consumer feedback.
Another noteworthy detail about HempCon, Ibudtender, a subsidiary of Cannabis Sativa, Inc, was the official voting platform of HempCon 420 Freedom Fest, keeping the competition fair and equal. A mix of industry/patient judges and testing data determines the best products and strains in the California market. Every entry is tested for potency, pesticides, microbiology, residual solvents and terpenes to ensure product safety.
On the financial front, the company continues to operate at a loss, perhaps contributing to its stock price woes. The balance sheet, however, does report more assets than liabilities. The company’s current market capitalization comes in at $75.58 million, on 19.38 million shares outstanding as of June 09, 2017. Although Cannabis Sativa, Inc continues to execute its expansion strategy, and there are no internal adverse events or circumstances (such as legal issues or product recalls) to account for the dropping stock price, the company looks to be hit by the overall bear market occurring right now in cannabis names. When the rebound comes, CBDS will be one of the first to bounce.